36970-20-4 Usage
Type of compound
Organic compound
Contains
An amine and a cyclohexane ring
Also known as
Harmaline
Classification
β-carboline alkaloid
Natural occurrence
Found in plant species such as Peganum harmala and Banisteriopsis caapi
Biological activities
Exhibits monoamine oxidase inhibition and GABA receptor modulation
Psychoactive effects
Studied for its potential psychoactive effects
Traditional use
Used in traditional medicine and shamanic rituals
Therapeutic applications
Investigated for potential treatment of neurological disorders and mental health conditions
Check Digit Verification of cas no
The CAS Registry Mumber 36970-20-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,6,9,7 and 0 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 36970-20:
(7*3)+(6*6)+(5*9)+(4*7)+(3*0)+(2*2)+(1*0)=134
134 % 10 = 4
So 36970-20-4 is a valid CAS Registry Number.
36970-20-4Relevant articles and documents
N2-(2-METHOXYPHENYL)PYRIMIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR CANCER PREVENTION OR TREATMENT CONTAINING SAME AS ACTIVE INGREDIENT
-
Paragraph 0216; 0219; 0220, (2018/05/03)
The present invention relates to a N2-(2-methoxyphenyl)pyrimidine derivative, a preparation method thereof, and a pharmaceutical composition for the prevention or treatment of cancer comprising the same as an active ingredient. The N2-(2-methoxyphenyl)pyrimidine derivative, the optical isomer thereof, or the pharmaceutically acceptable salt thereof of the present invention is very effective in suppressing anaplastic lymphoma kinase (ALK) activity and as a result it can improve the effectiveness of treatment on cancer cells having anaplastic lymphoma kinase (ALK) fusion proteins such as EML4-ALK and NPM-ALK, so that it can be effectively used as a pharmaceutical composition for preventing or treating cancer.
